U.S. markets open in 5 hours 22 minutes

Curaleaf's Select Brand Expands Into Connecticut's Medical Market

Select will be available at your local Connecticut dispensary

WAKEFIELD, Mass., June 15, 2020 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading multi-state cannabis operator in the United States, today announced it will expand its line of Select brand products into Connecticut. Select Elite Live cartridges will be available at local medical dispensaries across the state. 

Select, which was acquired by Curaleaf in February 2020, is available in Oregon, California, Arizona and Nevada, and recently expanded to Colorado, Michigan, Maryland and Oklahoma. All Select products are formulated with strain-specific terpenes to enhance flavor. Curaleaf will expand its product line in the coming months across several states to include Select Elite Live cartridges, oil infused with freshly harvested live resin terpenes.

"We are committed to providing essential medicine to over 40,000 patients in Connecticut with consistent, high quality Select products," said Joe Bayern, President of Curaleaf. "We also commend state lawmakers for adding chronic pain and Ehlers-Danlos Syndrome to its list of MMP qualifying conditions, and we look forward to providing quality medicine to current and future patients." 

During the COVID-19 outbreak, cannabis businesses have been deemed an essential service in most states, including Connecticut. Curaleaf remains committed to serving patients with the products and service they rely on while implementing heightened safety and sanitation measures in all its facilities.

About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading vertically integrated multi-state cannabis operator with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. The company currently operates in 17 states with 57 dispensaries, 15 cultivation sites and 24 processing sites. Curaleaf employs over 2,200 people across the United States. For more information please visit www.curaleaf.com.

For more information please visit www.curaleaf.com.

INVESTOR CONTACT
Curaleaf Holdings, Inc. 
Dan Foley, VP, Finance and Investor Relations
IR@curaleaf.com

MEDIA CONTACT
Curaleaf Holdings, Inc. 
Tracy Brady, VP Corporate Communications
media@curaleaf.com

FORWARD LOOKING STATEMENTS
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", " expects" or, "proposed", "is expected", "intends", "anticipates", " or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the expansion of the Select brand of products into Connecticut. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed September 23, 2019, which is available under the Company's SEDAR profile at www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

 

Cision

View original content:http://www.prnewswire.com/news-releases/curaleafs-select-brand-expands-into-connecticuts-medical-market-301077074.html

SOURCE Curaleaf Holdings, Inc.